Original Article
Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24‐week, post‐marketing SUNSHINE study
沙格列汀在中国2型糖尿病患者中单药治疗和与二甲双胍联合治疗24周的有效性和安全性分析:来自沙格列汀上市后的SUNSHINE研究结果